{
  "symbol": "TRIB",
  "company_name": "Trinity Bio ADR",
  "ir_website": "https://www.trinitybiotech.com/investor-relations/",
  "structured_data": [
    {
      "section_name": "Financial Reports & Notices",
      "links": [
        {
          "title": "Financial Reports & Notices",
          "url": "https://www.trinitybiotech.com/investor-relations/financial-reports/",
          "content": "[](https://www.trinitybiotech.com)\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [News & Events](/category/news-events/news/)\n  * EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\n  * [Login](/login/)\n\n\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n\nToggle navigation EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\nOK\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [Shop](https://www.trinitybiotech.com/shop/)\n  * [Login](/login/)\n\n\n\n[](https://www.trinitybiotech.com)\n\n## Investor Relations\n\n  * [Overview](https://www.trinitybiotech.com/investor-relations/)\n  * [Board of Directors](https://www.trinitybiotech.com/investor-relations/board-of-directors/)\n  * [Committees](https://www.trinitybiotech.com/investor-relations/committees/)\n  * [Financial Reports & Notices](https://www.trinitybiotech.com/investor-relations/financial-reports/)\n  * [Press Releases](https://www.trinitybiotech.com/investor-relations/press-releases/)\n  * [Investor Contact](https://www.trinitybiotech.com/investor-relations/investor-contact/)\n  * [SEC Filings](https://www.trinitybiotech.com/investor-relations/sec-filings/)\n  * [Corporate Presentations](https://www.trinitybiotech.com/autoimmune/trinity-disease/%ef%bf%bccorporate-presentations/)\n  * [Analyst Coverage](https://www.trinitybiotech.com/investor-relations/analyst-coverage/)\n\n\n\nNASDAQ:TRIB \n\n# Financial Reports & Notices\n\n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2024/09/Trinity-Biotech-Annual-Report-2023.pdf \"Download Trinity Biotech Annual Report 2023\")\n\nTrinity Biotech Annual Report 2023 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2024/09/2024-AGM-Notice-Sent-to-holders-of-Ordinary-Shares-1.pdf \"Download 2024 AGM Notice Sent to holders of Ordinary Shares\")\n\n2024 AGM Notice Sent to holders of Ordinary Shares \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2024/09/2024-AGM-Boards-Letter-Sent-to-holders-of-Ordinary-Shares.pdf \"Download 2024 AGM Board's Letter Sent to holders of Ordinary Shares\")\n\n2024 AGM Board's Letter Sent to holders of Ordinary Shares \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2024/05/20-F-Submitted-2.pdf \"Download Form 20-F 2023\")\n\nForm 20-F 2023 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2023/09/Trinity-Biotech-Annual-Report-2022-1.pdf \"Download Trinity Biotech Annual Report 2022\")\n\nTrinity Biotech Annual Report 2022 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2023/09/Notice-of-AGM-2023-1.pdf \"Download 2023 AGM Notice Sent to holders of Ordinary Shares*\")\n\n2023 AGM Notice Sent to holders of Ordinary Shares* \n  * *ADS holders should contact their brokers if they have any questions about voting their ADSs \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2023/09/Trinity-Biotech-plc-2023-Chairpersons-Letter-for-AGM.pdf \"Download 2023 AGM Board's Letter Sent to holders of Ordinary Shares**\")\n\n2023 AGM Board's Letter Sent to holders of Ordinary Shares** \n  * **ADS holders should contact their brokers if they have any questions about voting their ADSs \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2023/05/Form-20-F-2022-1.pdf \"Download Form 20-F 2022\")\n\nForm 20-F 2022 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2022/09/Trinity-Biotech-plc-Constitution-2022-Marked-to-Highlight-Proposed-Changes.pdf \"Download Trinity Biotech Constitution 2022 - Marked to Highlight Proposed Changes\")\n\nTrinity Biotech Constitution 2022 - Marked to Highlight Proposed Changes \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2022/09/2022-AGM-Notice-Sent-to-holders-of-Ordinary-Shares.pdf \"Download 2022 AGM Notice Sent to holders of Ordinary Shares*\")\n\n2022 AGM Notice Sent to holders of Ordinary Shares* \n  * *ADS holders should contact their brokers if they have any questions about voting their ADSs \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2022/09/2022-AGM-Boards-Letter-Sent-to-holders-of-Ordinary-Shares.pdf \"Download 2022 AGM Board's Letter Sent to holders of Ordinary Shares**\")\n\n2022 AGM Board's Letter Sent to holders of Ordinary Shares** \n  * **ADS holders should contact their brokers if they have any questions about voting their ADSs \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2022/09/Trinity-Biotech-plc-Annual-Report-for-2021.pdf \"Download Trinity Biotech Annual Report 2021\")\n\nTrinity Biotech Annual Report 2021 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2022/05/Form-20-F-2021.pdf \"Download Form 20-F 2021\")\n\nForm 20-F 2021 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2021/12/Trinity-Biotech-Notice-of-EGM-January-25-2022-Chairmans-Letter.pdf \"Download Trinity Biotech Notice of EGM January 25, 2022 - Chairman's Letter\")\n\nTrinity Biotech Notice of EGM January 25, 2022 - Chairman's Letter \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2021/12/Trinity-Biotech-Notice-of-EGM-January-25-2022.pdf \"Download Trinity Biotech Notice of EGM January 25, 2022\")\n\nTrinity Biotech Notice of EGM January 25, 2022 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2021/09/2021-AGM-Notice.pdf \"Download 2021 AGM Notice Sent to holders of Ordinary Shares* \")\n\n2021 AGM Notice Sent to holders of Ordinary Shares* \n  * *ADS holders should contact their brokers if they have any questions about voting their ADSs \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2021/09/2021-AGM-Chairmans-Letter.pdf \"Download 2021 AGM Chairman's Letter Sent to holders of Ordinary Shares**\")\n\n2021 AGM Chairman's Letter Sent to holders of Ordinary Shares** \n  * **ADS holders should contact their brokers if they have any questions about voting their ADSs \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2021/09/2020-Trinity-Biotech-Annual-Report-1.pdf \"Download Trinity Biotech Annual Report 2020\")\n\nTrinity Biotech Annual Report 2020 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2021/05/Trinity-Biotech-plc-2020-20-F.pdf \"Download Form 20-F 2020\")\n\nForm 20-F 2020 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2020/06/Form-20-F-2019-1.pdf \"Download Form 20-F 2019\")\n\nForm 20-F 2019 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2019/05/Form-20-F-2018.pdf \"Download Form 20-F 2018\")\n\nForm 20-F 2018 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2019/05/trib-20181231-05-14-19.zip \"Download 20-F 2018 \\(XBRL\\)\")\n\n20-F 2018 (XBRL) \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2018/04/Form-20-F-2017.pdf \"Download Form 20-F 2017\")\n\nForm 20-F 2017 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2018/04/trib-20171231-04-20-18.zip \"Download 20-F 2017 \\(XBRL\\)\")\n\n20-F 2017 (XBRL) \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2016.pdf \"Download Form 20-F 2016\")\n\nForm 20-F 2016 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2015.pdf \"Download Form 20-F 2015\")\n\nForm 20-F 2015 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2014.pdf \"Download Form 20-F 2014\")\n\nForm 20-F 2014 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2013.pdf \"Download Form 20-F 2013\")\n\nForm 20-F 2013 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2012.pdf \"Download Form 20-F 2012\")\n\nForm 20-F 2012 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2011.pdf \"Download Form 20-F 2011\")\n\nForm 20-F 2011 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2010.pdf \"Download Form 20-F 2010\")\n\nForm 20-F 2010 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2009.pdf \"Download Form 20-F 2009\")\n\nForm 20-F 2009 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2008.pdf \"Download Form 20-F 2008\")\n\nForm 20-F 2008 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2007.pdf \"Download Form 20-F 2007\")\n\nForm 20-F 2007 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2006.pdf \"Download Form 20-F 2006\")\n\nForm 20-F 2006 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2006.pdf \"Download Trinity Biotech Annual Report 2006\")\n\nTrinity Biotech Annual Report 2006 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2005.pdf \"Download Trinity Biotech Annual Report 2005\")\n\nTrinity Biotech Annual Report 2005 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2004.pdf \"Download Trinity Biotech Annual Report 2004\")\n\nTrinity Biotech Annual Report 2004 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2003.pdf \"Download Trinity Biotech Annual Report 2003\")\n\nTrinity Biotech Annual Report 2003 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2002.pdf \"Download Trinity Biotech Annual Report 2002\")\n\nTrinity Biotech Annual Report 2002 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2001.pdf \"Download Trinity Biotech Annual Report 2001\")\n\nTrinity Biotech Annual Report 2001 \n  * [ Download](https://www.trinitybiotech.com/wp-content/uploads/2015/01/Trinity-Biotech-Annual-Report-2000.pdf \"Download Trinity Biotech Annual Report 2000\")\n\nTrinity Biotech Annual Report 2000 \n\n\n\nWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent. [Privacy Policy](/privacy-statement/)\n\nCookie settingsREJECT ACCEPT\n\nCookies Policy\n\nClose\n\n#### Privacy Overview\n\nThis website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...\n\nNecessary \n\nNecessary \n\nAlways Enabled \n\nNecessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.\n\nNon Necessary \n\nnon-necessary\n\nAny cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.\n\nAnalytics \n\nanalytics\n\nAnalytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.\n\nPerformance \n\nperformance\n\nPerformance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.\n\nNecessary \n\nnecessary-2\n\nSave & Accept\n\n#### Choose Location\n\n[Global - Non USA/Canada](#) [USA](#) [Canada](#)\n"
        }
      ]
    },
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://www.trinitybiotech.com/investor-relations/press-releases/",
          "content": "[](https://www.trinitybiotech.com)\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [News & Events](/category/news-events/news/)\n  * EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\n  * [Login](/login/)\n\n\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n\nToggle navigation EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\nOK\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [Shop](https://www.trinitybiotech.com/shop/)\n  * [Login](/login/)\n\n\n\n[](https://www.trinitybiotech.com)\n\n## Investor Relations\n\n  * [Overview](https://www.trinitybiotech.com/investor-relations/)\n  * [Board of Directors](https://www.trinitybiotech.com/investor-relations/board-of-directors/)\n  * [Committees](https://www.trinitybiotech.com/investor-relations/committees/)\n  * [Financial Reports & Notices](https://www.trinitybiotech.com/investor-relations/financial-reports/)\n  * [Press Releases](https://www.trinitybiotech.com/investor-relations/press-releases/)\n  * [Investor Contact](https://www.trinitybiotech.com/investor-relations/investor-contact/)\n  * [SEC Filings](https://www.trinitybiotech.com/investor-relations/sec-filings/)\n  * [Corporate Presentations](https://www.trinitybiotech.com/autoimmune/trinity-disease/%ef%bf%bccorporate-presentations/)\n  * [Analyst Coverage](https://www.trinitybiotech.com/investor-relations/analyst-coverage/)\n\n\n\nNASDAQ:TRIB \n\n# Press Releases\n\n#### [ Trinity Biotech Announces Q3 2024 Financial Results ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-q3-2024-financial-results/ \"Permalink to Trinity Biotech Announces Q3 2024 Financial Results\")\n\nNovember 15, 2024\n\n[Trinity Biotech Announces Q3 2024 Financial Results](https://www.trinitybiotech.com/wp-content/uploads/2024/11/Trinity-Biotech-Announces-Q3-2024-Financial-Results.pdf)\n\n#### [ Trinity Biotech Regains Compliance with Nasdaq Listing Requirements ](https://www.trinitybiotech.com/press-releases/trinity-biotech-regains-compliance-with-nasdaq-listing-requirements/ \"Permalink to Trinity Biotech Regains Compliance with Nasdaq Listing Requirements\")\n\nNovember 7, 2024\n\n[Trinity Biotech Regains Compliance with Nasdaq Listing Requirements](https://www.trinitybiotech.com/wp-content/uploads/2024/11/Trinity-Biotech-Regains-Compliance-with-Nasdaq-Listing-Requirements.pdf)\n\n#### [ Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture ](https://www.trinitybiotech.com/press-releases/trinity-biotech-enters-oncology-space-with-acquisition-of-prostate-cancer-focused-epicapture/ \"Permalink to Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture\")\n\nOctober 25, 2024\n\n[Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture](https://www.trinitybiotech.com/wp-content/uploads/2024/10/Trinity-Biotech-Enters-Oncology-Space-with-Acquisition-of-Prostate-Cancer-Focused-EpiCapture.pdf)\n\n#### [ Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-strategic-investment-in-novus-diagnostics-to-advance-rapid-sepsis-testing-platform/ \"Permalink to Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform\")\n\nOctober 25, 2024\n\n[Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform](https://www.trinitybiotech.com/wp-content/uploads/2024/10/Trinity-Biotech-Announces-Strategic-Investment-in-Novus-Diagnostics-to-Advance-Rapid-Sepsis-Testing-Platform.pdf)\n\n#### [ Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-acquisition-of-metabolomics-diagnostics-to-grow-presence-in-maternal-health-market/ \"Permalink to Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market\")\n\nSeptember 25, 2024\n\n[Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market](https://www.trinitybiotech.com/wp-content/uploads/2024/09/Trinity-Biotech-Announces-Acquisition-of-Metabolomics-Diagnostics-to-Grow-Presence-in-Maternal-Health-Market.pdf)\n\n#### [ Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer ](https://www.trinitybiotech.com/news-events/events/trinity-biotech-to-initiate-cgm-market-study-in-india-in-furtherance-of-intended-collaboration-with-bayer/ \"Permalink to Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer\")\n\nSeptember 19, 2024\n\n[Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer](https://www.trinitybiotech.com/wp-content/uploads/2024/09/Trinity-Biotech-to-Initiate-CGM-Market-Study-in-India-in-Furtherance-of-Intended-Collaboration-with-Bayer-.pdf)\n\n#### [ Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology ](https://www.trinitybiotech.com/press-releases/trinity-biotech-provides-an-update-on-the-continued-development-of-its-continuous-glucose-monitor-technology/ \"Permalink to Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology\")\n\nSeptember 12, 2024\n\n[Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology](https://www.trinitybiotech.com/wp-content/uploads/2024/09/Trinity-Biotech-Provides-an-Update-on-the-Continued-Development-of-Its-Continuous-Glucose-Monitor-Technology.pdf)\n\n#### [ Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer ](https://www.trinitybiotech.com/press-releases/trinity-biotech-appoints-global-life-sciences-leader-as-chief-commercial-officer/ \"Permalink to Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer\")\n\nSeptember 4, 2024\n\n[Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer](https://www.trinitybiotech.com/wp-content/uploads/2024/09/Trinity-Biotech-Appoints-Global-Life-Sciences-Leader-as-Chief-Commercial-Officer.pdf)\n\n#### [ Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-increased-orders-for-trinscreen-hiv-and-raises-guidance-for-2024-sales/ \"Permalink to Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales\")\n\nAugust 27, 2024\n\n[Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales](https://www.trinitybiotech.com/wp-content/uploads/2024/08/Trinity-Biotech-Announces-Increased-Orders-for-TrinScreen-HIV-and-Raises-Guidance-For-2024-Sales.pdf)\n\n#### [ Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director ](https://www.trinitybiotech.com/press-releases/trinity-biotech-appoints-diabetes-care-veteran-as-biosensor-marketing-director/ \"Permalink to Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director\")\n\nAugust 21, 2024\n\n[Trinity Biotech Appoints Diabetes Care Veteran as Biosensor](https://www.trinitybiotech.com/wp-content/uploads/2024/09/Trinity-Biotech-Appoints-Diabetes-Care-Veteran-as-Biosensor.pdf)\n\n#### [ Trinity Biotech Announces Q2 2024 Financial Results ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-q2-2024-financial-results/ \"Permalink to Trinity Biotech Announces Q2 2024 Financial Results\")\n\nAugust 19, 2024\n\n[Trinity Biotech Announces Q2 2024 Financial Results](https://www.trinitybiotech.com/wp-content/uploads/2024/08/Trinity-Biotech-Announces-Q2-2024-Financial-Results.pdf)\n\n#### [ Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements ](https://www.trinitybiotech.com/press-releases/trinity-biotech-obtains-an-extension-to-demonstrate-compliance-with-nasdaq-listing-requirements/ \"Permalink to Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements\")\n\nAugust 8, 2024\n\n[Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements](https://www.trinitybiotech.com/wp-content/uploads/2024/08/Trinity-Biotech-Obtains-an-Extension-to-Demonstrate-Compliance-With-Nasdaq-Listing-Requirements-1.pdf)\n\n#### [ Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience ](https://www.trinitybiotech.com/press-releases/trinity-biotech-provides-preliminary-second-quarter-2024-update-and-enters-into-uk-distribution-agreement-with-medscience/ \"Permalink to Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience\")\n\nAugust 6, 2024\n\n[Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience](https://www.trinitybiotech.com/wp-content/uploads/2024/08/Trinity-Biotech-Provides-Preliminary-Second-Quarter-2024-Update-and-Enters-into-UK-Distribution-Agreement-with-MedScience.pdf)\n\n#### [ Trinity Biotech Announces Appointment of A New CFO ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-appointment-of-a-new-cfo/ \"Permalink to Trinity Biotech Announces Appointment of A New CFO\")\n\nJuly 12, 2024\n\n[Trinity Biotech Announces Appointment of A New CFO](https://www.trinitybiotech.com/wp-content/uploads/2024/07/Trinity-Biotech-Announces-Appointment-of-A-New-CFO.pdf)\n\n#### [ Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-q1-2024-financial-results-and-reiterates-guidance/ \"Permalink to Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance\")\n\nMay 24, 2024\n\n[Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance](https://www.trinitybiotech.com/wp-content/uploads/2024/05/Trinity-Biotech-Announces-Q1-2024-Financial-Results-and-Reiterates-Guidance.pdf)\n\n#### [ Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI ](https://www.trinitybiotech.com/press-releases/trinity-biotech-announces-strategic-collaboration-with-medical-artificial-intelligence-company-pulseai/ \"Permalink to Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI\")\n\nMay 16, 2024\n\n[Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI](https://www.trinitybiotech.com/wp-content/uploads/2024/05/Trinity-Biotech-Announces-Strategic-Collaboration-with-Medical-Artificial-Intelligence-Company-PulseAI-1.pdf)\n\n#### [ Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development ](https://www.trinitybiotech.com/press-releases/trinity-biotech-welcomes-avinash-kale-as-continuous-glucose-monitor-programme-director-to-advance-innovation-and-development/ \"Permalink to Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development\")\n\nMay 9, 2024\n\n[Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development](https://www.trinitybiotech.com/wp-content/uploads/2024/05/Trinity-Biotech-Welcomes-Avinash-Kale-as-Continuous-Glucose-Monitor-Programme-Director-to-Advance-Innovation-and-Development-1.pdf)\n\n#### [ Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates ](https://www.trinitybiotech.com/news-events/news/trinity-biotech-announces-fourth-quarter-and-fiscal-year-2023-financial-results-business-updates/ \"Permalink to Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates\")\n\nApril 4, 2024\n\n[Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results Business Updates](https://www.trinitybiotech.com/wp-content/uploads/2024/04/Trinity-Biotech-Announces-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results-Business-Updates.pdf)\n\n#### [ Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change ](https://www.trinitybiotech.com/press-releases/trinity-biotech-plc-finalizes-effective-date-of-ads-ratio-change/ \"Permalink to Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change\")\n\nFebruary 28, 2024\n\n[Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change](https://www.trinitybiotech.com/wp-content/uploads/2024/02/Trinity-Biotech-Plc-Finalizes-Effective-Date-of-ADS-Ratio-Change.pdf)\n\n#### [ Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change ](https://www.trinitybiotech.com/news-events/trinity-biotech-plc-announces-plan-to-implement-ads-ratio-change/ \"Permalink to Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change\")\n\nFebruary 28, 2024\n\n[Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change](https://www.trinitybiotech.com/wp-content/uploads/2024/02/Trinity-Biotech-Plc-Announces-Plan-to-Implement-ADS-Ratio-Change.pdf)\n\n  * 1\n  * [2](https://www.trinitybiotech.com/investor-relations/press-releases/page/2/)\n  * [3](https://www.trinitybiotech.com/investor-relations/press-releases/page/3/)\n  * …\n  * [12](https://www.trinitybiotech.com/investor-relations/press-releases/page/12/)\n  * [»](https://www.trinitybiotech.com/investor-relations/press-releases/page/2/)\n\n\n\nWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent. [Privacy Policy](/privacy-statement/)\n\nCookie settingsREJECT ACCEPT\n\nCookies Policy\n\nClose\n\n#### Privacy Overview\n\nThis website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...\n\nNecessary \n\nNecessary \n\nAlways Enabled \n\nNecessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.\n\nNon Necessary \n\nnon-necessary\n\nAny cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.\n\nAnalytics \n\nanalytics\n\nAnalytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.\n\nPerformance \n\nperformance\n\nPerformance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.\n\nNecessary \n\nnecessary-2\n\nSave & Accept\n\n#### Choose Location\n\n[Global - Non USA/Canada](#) [USA](#) [Canada](#)\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://www.trinitybiotech.com/investor-relations/sec-filings/",
          "content": "[](https://www.trinitybiotech.com)\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [News & Events](/category/news-events/news/)\n  * EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\n  * [Login](/login/)\n\n\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n\nToggle navigation EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\nOK\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [Shop](https://www.trinitybiotech.com/shop/)\n  * [Login](/login/)\n\n\n\n[](https://www.trinitybiotech.com)\n\n## Investor Relations\n\n  * [Overview](https://www.trinitybiotech.com/investor-relations/)\n  * [Board of Directors](https://www.trinitybiotech.com/investor-relations/board-of-directors/)\n  * [Committees](https://www.trinitybiotech.com/investor-relations/committees/)\n  * [Financial Reports & Notices](https://www.trinitybiotech.com/investor-relations/financial-reports/)\n  * [Press Releases](https://www.trinitybiotech.com/investor-relations/press-releases/)\n  * [Investor Contact](https://www.trinitybiotech.com/investor-relations/investor-contact/)\n  * [SEC Filings](https://www.trinitybiotech.com/investor-relations/sec-filings/)\n  * [Corporate Presentations](https://www.trinitybiotech.com/autoimmune/trinity-disease/%ef%bf%bccorporate-presentations/)\n  * [Analyst Coverage](https://www.trinitybiotech.com/investor-relations/analyst-coverage/)\n\n\n\nNASDAQ:TRIB \n\n# SEC Filings\n\n**[Please click here for SEC filing history](http://www.sec.gov/cgi-bin/browse-edgar?CIK=0000888721&action=getcompany \"SEC Filings\")**\n\nWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent. [Privacy Policy](/privacy-statement/)\n\nCookie settingsREJECT ACCEPT\n\nCookies Policy\n\nClose\n\n#### Privacy Overview\n\nThis website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...\n\nNecessary \n\nNecessary \n\nAlways Enabled \n\nNecessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.\n\nNon Necessary \n\nnon-necessary\n\nAny cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.\n\nAnalytics \n\nanalytics\n\nAnalytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.\n\nPerformance \n\nperformance\n\nPerformance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.\n\nNecessary \n\nnecessary-2\n\nSave & Accept\n\n#### Choose Location\n\n[Global - Non USA/Canada](#) [USA](#) [Canada](#)\n"
        }
      ]
    },
    {
      "section_name": "Corporate Presentations",
      "links": [
        {
          "title": "Corporate Presentations",
          "url": "https://www.trinitybiotech.com/autoimmune/trinity-disease/%ef%bf%bccorporate-presentations/",
          "content": "[](https://www.trinitybiotech.com)\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [News & Events](/category/news-events/news/)\n  * EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\n  * [Login](/login/)\n\n\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n\nToggle navigation EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\nOK\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [Shop](https://www.trinitybiotech.com/shop/)\n  * [Login](/login/)\n\n\n\n[](https://www.trinitybiotech.com)\n\n# Corporate Presentations\n\n**March 7th 2024 Emerging Growth Conference**\n\n[Emerging Growth Conference March 7th 2024](https://www.trinitybiotech.com/wp-content/uploads/2024/03/Emerging-Growth-Conference-07032024.pdf)\n\n**January 31 st Biosensor Acquisition Investor Call**\n\n[Trinity Biotech Investor Call Presentation (January 31, 2023)](https://www.trinitybiotech.com/wp-content/uploads/2024/01/Trinity-Biotech-Investor-Presentation.pdf)\n\nWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent. [Privacy Policy](/privacy-statement/)\n\nCookie settingsREJECT ACCEPT\n\nCookies Policy\n\nClose\n\n#### Privacy Overview\n\nThis website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...\n\nNecessary \n\nNecessary \n\nAlways Enabled \n\nNecessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.\n\nNon Necessary \n\nnon-necessary\n\nAny cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.\n\nAnalytics \n\nanalytics\n\nAnalytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.\n\nPerformance \n\nperformance\n\nPerformance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.\n\nNecessary \n\nnecessary-2\n\nSave & Accept\n\n#### Choose Location\n\n[Global - Non USA/Canada](#) [USA](#) [Canada](#)\n"
        }
      ]
    },
    {
      "section_name": "Analyst Coverage",
      "links": [
        {
          "title": "Analyst Coverage",
          "url": "https://www.trinitybiotech.com/investor-relations/analyst-coverage/",
          "content": "[](https://www.trinitybiotech.com)\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [News & Events](/category/news-events/news/)\n  * EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\n  * [Login](/login/)\n\n\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n\nToggle navigation EUR, € CAD, $ USD, $\n\nWOOCS v.1.3.4\n\nOK\n\n  * [Our Company](https://www.trinitybiotech.com/our-company/)\n  * [Our Products ](#)\n    * [Point of Care](https://www.trinitybiotech.com/point-of-care-5/)\n    * [Infectious Disease](https://www.trinitybiotech.com/infectious-disease/)\n    * [Haemoglobins](https://www.trinitybiotech.com/haemoglobins/)\n    * [Autoimmune](https://www.trinitybiotech.com/autoimmune/)\n    * [Clinical Chemistry](https://www.trinitybiotech.com/clinical-chemistry/)\n    * [Urinalysis](https://www.trinitybiotech.com/urinalysis/)\n  * [Immco Reference Lab Services](https://www.trinitybiotech.com/reference-lab-services/)\n  * [Investor Relations](https://www.trinitybiotech.com/investor-relations/)\n  * [COVID-19 ](#)\n    * [Bartels® FlexTrans™ Transport Medium](https://www.trinitybiotech.com/products/flex-trans-bulk-pack/)\n\n\n  * [Location: ](#)\n    * [USA]()\n    * [Canada]()\n    * [Global ]()\n  * [Careers](/careers/)\n  * [Contact Us](/contact-us)\n  * [Technical Support](/contact-us/technical-support/)\n  * [Shop](https://www.trinitybiotech.com/shop/)\n  * [Login](/login/)\n\n\n\n[](https://www.trinitybiotech.com)\n\n## Investor Relations\n\n  * [Overview](https://www.trinitybiotech.com/investor-relations/)\n  * [Board of Directors](https://www.trinitybiotech.com/investor-relations/board-of-directors/)\n  * [Committees](https://www.trinitybiotech.com/investor-relations/committees/)\n  * [Financial Reports & Notices](https://www.trinitybiotech.com/investor-relations/financial-reports/)\n  * [Press Releases](https://www.trinitybiotech.com/investor-relations/press-releases/)\n  * [Investor Contact](https://www.trinitybiotech.com/investor-relations/investor-contact/)\n  * [SEC Filings](https://www.trinitybiotech.com/investor-relations/sec-filings/)\n  * [Corporate Presentations](https://www.trinitybiotech.com/autoimmune/trinity-disease/%ef%bf%bccorporate-presentations/)\n  * [Analyst Coverage](https://www.trinitybiotech.com/investor-relations/analyst-coverage/)\n\n\n\nNASDAQ:TRIB \n\n# Analyst Coverage\n\n  * Sidoti & Company, LLC \n\n\n\nWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent. [Privacy Policy](/privacy-statement/)\n\nCookie settingsREJECT ACCEPT\n\nCookies Policy\n\nClose\n\n#### Privacy Overview\n\nThis website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities...\n\nNecessary \n\nNecessary \n\nAlways Enabled \n\nNecessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.\n\nNon Necessary \n\nnon-necessary\n\nAny cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.\n\nAnalytics \n\nanalytics\n\nAnalytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.\n\nPerformance \n\nperformance\n\nPerformance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.\n\nNecessary \n\nnecessary-2\n\nSave & Accept\n\n#### Choose Location\n\n[Global - Non USA/Canada](#) [USA](#) [Canada](#)\n"
        }
      ]
    }
  ]
}